Max Robotics — Global Service Robot Directory + US Certification

About

Alwyn Gomez is a rising leader in neurocritical care and cerebrovascular physiology, whose work is redefining how we monitor and understand brain blood flow dynamics. His most influential contribution is the development and validation of a **continuous, entirely non-invasive method for assessing cerebrovascular reactivity**—a technique that promises to transform bedside and outpatient care for patients with brain injury or stroke. This landmark 2020 paper, with 46 citations, introduces a practical approach to a parameter previously difficult to measure without invasive monitoring. Gomez has further advanced the field by championing the use of robotic transcranial Doppler (TCD) for continuous, non-invasive monitoring, as highlighted in his 2021 work (17 citations), which opens doors for subacute and outpatient settings. Demonstrating a forward-looking scope, his 2024 systematic review (9 citations) explores the potential of the CorPath GRX robotic system in neuroendovascular surgery, mapping the challenges and opportunities for precision robotics in the operating room. By bridging non-invasive monitoring with robotic innovation, Gomez is shaping a future where cerebrovascular care is both safer and more accessible.